J Y Borg - JoVE Visualize

Showing results (31-40 of 60) with videos related to

Pageof 6

Sort By:

Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1983

[Prevention of the thromboembolic risk during the operative period in a patient with a congenital antithrombin III deficiency]A Franceschi, J Testard, J Y Borg, et al.

British Journal of Haematology|March 1, 1995

Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein CS Beufé, J Y Borg, M Vasse, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993

Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytesM Vasse, S S Mirshahi, J Soria, et al.

Presse Medicale (Paris, France : 1983)|June 8, 1991

[Influence of protein S deficiency on the arterial thrombosis risk]M L Wiesel, J Y Borg, L Grunebaum, et al.

Cerebrovascular Diseases (Basel, Switzerland)|March 27, 2002

Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patientsA Blohorn, E Guegan-Massardier, A Triquenot, et al.

Thrombosis and Haemostasis|February 1, 1997

Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la ThromboseJ Goudemand, C Caron, D De Prost, et al.

FEBS Letters|June 18, 1990

Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin bindingJ Y Borg, S O Brennan, R W Carrell, et al.

The American Journal of Gastroenterology|May 26, 2001

Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel diseaseC Guédon, V Le Cam-Duchez, O Lalaude, et al.

The European Journal of Medicine|May 1, 1993

Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidismH Levesque, J Y Borg, N Cailleux, et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004

Thrombophilia and fetal growth restrictionE Verspyck, J Y Borg, V Le Cam-Duchez, et al.

Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:

Pageof 6

Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1983

[Prevention of the thromboembolic risk during the operative period in a patient with a congenital antithrombin III deficiency]A Franceschi, J Testard, J Y Borg, et al.

British Journal of Haematology|March 1, 1995

Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein CS Beufé, J Y Borg, M Vasse, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993

Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytesM Vasse, S S Mirshahi, J Soria, et al.

Presse Medicale (Paris, France : 1983)|June 8, 1991

[Influence of protein S deficiency on the arterial thrombosis risk]M L Wiesel, J Y Borg, L Grunebaum, et al.

Cerebrovascular Diseases (Basel, Switzerland)|March 27, 2002

Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patientsA Blohorn, E Guegan-Massardier, A Triquenot, et al.

Thrombosis and Haemostasis|February 1, 1997

Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la ThromboseJ Goudemand, C Caron, D De Prost, et al.

FEBS Letters|June 18, 1990

Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin bindingJ Y Borg, S O Brennan, R W Carrell, et al.

The American Journal of Gastroenterology|May 26, 2001

Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel diseaseC Guédon, V Le Cam-Duchez, O Lalaude, et al.

The European Journal of Medicine|May 1, 1993

Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidismH Levesque, J Y Borg, N Cailleux, et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004

Thrombophilia and fetal growth restrictionE Verspyck, J Y Borg, V Le Cam-Duchez, et al.

Pageof 6